Mental Health and Disorders of Sex Development/Intersex Conditions in Iranian Culture: Congenital Adrenal Hyperplasia, 5-α Reductase Deficiency-Type 2, and Complete Androgen Insensitivity Syndrome.

Sixty-one patients (22 patients with congenital adrenal hyperplasia [CAH] with a mean age of 14.86 years [range, 5-23], 20 patients with 5-α reductase deficiency type 2 [5α-RD-2] with a mean age of 19.5 years [range, 5-29], and 19 patients with complete androgen insensitivity syndrome [CAIS] with a...

Descripción completa

Detalles Bibliográficos
Publicado en:Archives of Sexual Behavior Vol. 47; no. 4; pp. 931 - 943
Autores principales: Khorashad, Behzad S., Aghili, Zahra, Kreukels, Baudewijntje P. C., Reid, Alistair G., Roshan, Ghasem M., Hiradfar, Mehran, Talaei, Ali, Cohen Kettenis, Peggy T.
Formato: journal article
Publicado: Springer Nature May2018
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=128968734&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 128968734
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        00040002
        ASX
      jtl: Archives of Sexual Behavior
      issn: 00040002
      maglogo: N
    pubinfo:
      dt: May2018
      vid: 47
      iid: 4
      pid: 237
      pub: Springer Nature
    artinfo:
      ui:
        128968734
        10.1007/s10508-017-1139-6
      ppf: 931
      ppct: 12
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
              size: 421KB
      tig:
        atl: Mental Health and Disorders of Sex Development/Intersex Conditions in Iranian Culture: Congenital Adrenal Hyperplasia, 5-α Reductase Deficiency-Type 2, and Complete Androgen Insensitivity Syndrome.
      aug:
        au:
          Khorashad, Behzad S.
          Aghili, Zahra
          Kreukels, Baudewijntje P. C.
          Reid, Alistair G.
          Roshan, Ghasem M.
          Hiradfar, Mehran
          Talaei, Ali
          Cohen Kettenis, Peggy T.
        affil:
          Transgender Studies Center, Mashhad University of Medical Sciences, No. 17, Toufigh 9 Lane, Shahid Sadeghi Blvd., 91858-84714, Mashhad, Iran
          Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Ibn-e-Sina Hospital, Horeameli Avenue, 91959, Mashhad, Iran
          Department of Medical Psychology and Center of Expertise on Gender Dysphoria, VU University Medical Center, Amsterdam, The Netherlands
          Molecular Pathology Unit, Liverpool Clinical Laboratories, Liverpool, UK
          Department of Pediatric Surgery, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
      su:
        Sex differentiation disorders
        Mental health
        Intersex people
        Schizophrenia
        Adrenogenital syndrome
        Reductases
        Androgen-insensitivity syndrome
      sug:
        subj:
          Sex differentiation disorders
          Mental health
          Intersex people
          Schizophrenia
          Offices of Mental Health Practitioners (except Physicians)
          Adrenogenital syndrome
          Reductases
          Androgen-insensitivity syndrome
      keyword:
        5-α reductase deficiency-2
        Complete androgen insensitivity syndrome
        Congenital adrenal hyperplasia
        Disorders of sex development
        Gender dysphoria
        5-α reductase deficiency-2
        Complete androgen insensitivity syndrome
        Congenital adrenal hyperplasia
        Disorders of sex development
        Gender dysphoria
      ab: Sixty-one patients (22 patients with congenital adrenal hyperplasia [CAH] with a mean age of 14.86 years [range, 5-23], 20 patients with 5-α reductase deficiency type 2 [5α-RD-2] with a mean age of 19.5 years [range, 5-29], and 19 patients with complete androgen insensitivity syndrome [CAIS] with a mean age of 18.26 years [range, 5-28]) were evaluated using the Kiddie Schedule for Affective Disorders and Schizophrenia, the Structured Clinical Interview for DSM-IV Axis I, Axis II, and the Global Assessment Functioning Scale. All participants were female-assigned at birth. Ten patients (16.4%) transitioned to the male gender. Overall, 68% of patients had one or more lifetime Axis I disorders, including 63.6% of the CAH participants, 90% of 5α-RD-2 participants, and 52.6% of the CAIS participants. The most commonly observed were affective disorders (27.9%), gender identity disorder (27.9%), and anxiety (16.4%). Our study demonstrates that mental health of Iranian patients with DSD is at risk. This might be due to the fact that patients with DSD conditions are mostly treated medically and their mental health is often superficially addressed in developing countries such as Iran, at least in the past. We argue that it is important to pay attention to the mental health issues of patients with DSD and focus on specific issues, which may vary cross-culturally.
      pubtype: Academic Journal
      doctype: journal article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N